Vericel (VCEL) Net Equity Issued and Repurchased (2010 - 2026)

Vericel (VCEL) posted Net Equity Issued and Repurchased of $2.9 million for Q2 2026, up 82.85% sequentially from $1.6 million in Q1 2026, and up 59.84% YoY from $1.8 million in Q2 2025.

Vericel (VCEL) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Vericel has reported Net Equity Issued and Repurchased for 10 years, with the latest figure at $2.9 million in Q2 2026.

  • Quarterly Net Equity Issued and Repurchased rose 59.84% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.2 million (down 70.49% YoY) and the FY2025 annual result came in at $13.9 million, down 43.16% from the prior year.
  • Net Equity Issued and Repurchased advanced to $2.9 million in Q2 2026 per VCEL's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $9.4 million in Q1 2025 and troughed at $746000.0 in Q2 2022.
  • A 5-year average of $3.1 million and a median of $1.6 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2024 and 2026: Net Equity Issued and Repurchased soared 423.88% in 2024, then tumbled 83.39% in 2026.
  • Over 5 years, Net Equity Issued and Repurchased stood at $829000.0 in 2022, then jumped by 67.19% to $1.4 million in 2023, then jumped by 423.88% to $7.3 million in 2024, then plunged by 82.72% to $1.3 million in 2025, then soared by 127.73% to $2.9 million in 2026.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $2.9 million, $1.6 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Vericel 2.26 Bn 2.10 Bn 56.40 Mn 2.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.86 Mn
Jun 30, 2026 2.86 Mn
Mar 31, 2026 1.56 Mn
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.26 Mn
Dec 31, 2025 1.26 Mn
Sep 30, 2025 1.48 Mn
Sep 30, 2025 1.48 Mn
Jun 30, 2025 1.79 Mn
Jun 30, 2025 1.79 Mn
Mar 31, 2025 9.41 Mn
Mar 31, 2025 9.41 Mn
Dec 31, 2024 7.26 Mn
Dec 31, 2024 7.26 Mn
Sep 30, 2024 5.80 Mn
Sep 30, 2024 5.80 Mn
Jun 30, 2024 4.43 Mn
Jun 30, 2024 4.43 Mn
Mar 31, 2024 7.03 Mn
Mar 31, 2024 7.03 Mn